No abstract

Topical oral decontamination with CHX or CHX/COL reduces the incidence of VAP.

clinicaltrials.gov Identifier: NCT01785290.

trialregister.nlIdentifier: NTR1780.

Based on the results of 58 randomized studies on ventilator-associated pneumonia prevention, the attributable mortality rate of ventilator-associated pneumonia was estimated to be 9% and ranged between 3% and 17% in subgroup analyses. Together with the results of other recent studies, there is cumulative evidence that the attributable mortality resulting from ventilator-associated pneumonia is approximately 10%.